摘要 |
Substituted heterocyclic derivatives are provided which have the structure wherein Z<SUP>1 </SUP>is (CH<SUB>2</SUB>)<SUB>q </SUB>or C-O; Z<SUP>2 </SUP>is (CH<SUB>2</SUB>)<SUB>p </SUB>or C-O; D is -CH- or C-O or (CH<SUB>2</SUB>)<SUB>m </SUB>where m is 0, 1, 2 or 3; n=0, 1 or 2; p=1 or 2; q=0, 1 or 2; Q is C or N; X is CH or N; X<SUB>2 </SUB>is C, N, O or S; X<SUB>3 </SUB>is C, N, O or S; X<SUB>4 </SUB>is C, N, O or S; X<SUB>5 </SUB>is C, N, O or S; X<SUB>6 </SUB>is C, N, O or S; provided that at least one of X<SUB>2</SUB>, X<SUB>3</SUB>, X<SUB>4</SUB>, X<SUB>5 </SUB>and X<SUB>6 </SUB>is N; and at least one of X<SUB>2</SUB>, X<SUB>3</SUB>, X<SUB>4</SUB>, X<SUB>5 </SUB>and X<SUB>6 </SUB>is C; A, B, R<SUP>1</SUP>, R<SUP>2</SUP>, R<SUP>2a</SUP>, R<SUP>2b</SUP>, R<SUP>4</SUP>, R<SUP>3</SUP>, E, Z and Y are as defined herein. In addition, a method is provided for treating diabetes, Type 2 diabetes, insulin resistance, hyperglycemia, hyperinsulinemia, elevated blood levels of fatty acids or glycerol, hyperlipidemia, obesity, hypertriglyceridemia, Syndrome X, or atherosclerosis, wherein the substituted heterocyclic derivatives are administered in a therapeutically effective amount to a patient.
|